These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9209895

  • 1. Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects.
    Moro M, Maraschini C, Cavagnini F.
    Gynecol Endocrinol; 1997 Jun; 11(3):155-62. PubMed ID: 9209895
    [Abstract] [Full Text] [Related]

  • 2. Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and cortisol in hyperprolactinemic-amenorrheic women.
    Seki K, Mitsui C, Nagata I.
    Gynecol Obstet Invest; 1995 Jun; 40(1):42-5. PubMed ID: 7557642
    [Abstract] [Full Text] [Related]

  • 3. No difference between micro- and macroprolactinomas in the prolactin responsiveness to metoclopramide and dopamine administration.
    Maraschini C, Moro M, Toja P, Braga M, Cavagnini F.
    Gynecol Endocrinol; 1996 Feb; 10(1):7-15. PubMed ID: 8737186
    [Abstract] [Full Text] [Related]

  • 4. Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion.
    Nishida S, Matsuki M, Adachi N, Horino M, Yoneda M, Endoh M, Oyama H, Kikuoka M, Otsuka R, Ishii R.
    J Clin Endocrinol Metab; 1987 May; 64(5):995-1001. PubMed ID: 3031125
    [Abstract] [Full Text] [Related]

  • 5. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O, Beauregard H, Somma M, Comtois R, Jilwan N, Hardy J.
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [Abstract] [Full Text] [Related]

  • 6. Effect of dopamine, dopamine D-1 and D-2 receptor modulation on ACTH and cortisol levels in normal men and women.
    Boesgaard S, Hagen C, Andersen AN, Fenger M, Eldrup E.
    Acta Endocrinol (Copenh); 1990 Jan; 122(1):29-36. PubMed ID: 1968308
    [Abstract] [Full Text] [Related]

  • 7. Male patients with paranoid schizophrenia have greater ACTH and cortisol secretion in response to metoclopramide-induced AVP release.
    Walsh P, Spelman L, Sharifi N, Thakore JH.
    Psychoneuroendocrinology; 2005 Jun; 30(5):431-7. PubMed ID: 15721055
    [Abstract] [Full Text] [Related]

  • 8. The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman.
    Verhelst J, Beckers A, Abs R.
    Fertil Steril; 1995 Nov; 64(5):969-71. PubMed ID: 7589643
    [Abstract] [Full Text] [Related]

  • 9. Prolactin response to metoclopramide and thyrotropin-releasing hormone in normoprolactinemic and hyperprolactinemic women: a comparison of diagnostic validity.
    Bussen S, Brosemann N, Steck T.
    Gynecol Endocrinol; 1996 Apr; 10(2):83-90. PubMed ID: 8701791
    [Abstract] [Full Text] [Related]

  • 10. Responses of growth hormone to metoclopramide in normal women and amenorrheic women with or without hyperprolactinemia.
    Seki K, Kato K.
    Endocrinol Jpn; 1986 Oct; 33(5):721-5. PubMed ID: 3830074
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
    Veglio F, Pinna G, Rabbia F, Mulatero P, Chiandussi L.
    Minerva Endocrinol; 1992 Oct; 17(1):43-6. PubMed ID: 1323053
    [Abstract] [Full Text] [Related]

  • 13. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K, Yamazaki M, Ikeda K, Yaginuma K, Hashimoto S, Fukuchi S.
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [Abstract] [Full Text] [Related]

  • 14. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ, Vanrell C, Gich I, Urgell E, Calaf J.
    Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
    [Abstract] [Full Text] [Related]

  • 15. Parallelism in the luteinizing hormone responses to opioid and dopamine antagonists in hyperprolactinemic women with pituitary microadenoma.
    Seki K, Kato K, Shima K.
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1225-8. PubMed ID: 3760121
    [Abstract] [Full Text] [Related]

  • 16. Dopamine-mediated effects induced by metoclopramide simultaneously on adrenocorticotropic hormone and prolactin in patients with pituitary and/or hypothalamic disorders.
    Nishida S, Matsuki M, Horino M, Kawai Y, Tsushima K, Yoneda M, Oyama H, Ishii R.
    Clin Chim Acta; 1990 Oct 15; 190(3):269-75. PubMed ID: 2174755
    [No Abstract] [Full Text] [Related]

  • 17. Assessment of pituitary function after transsphenoidal hypophysectomy in beagle dogs.
    Meij BP, Mol JA, van den Ingh TS, Bevers MM, Hazewinkel HA, Rijnberk A.
    Domest Anim Endocrinol; 1997 Mar 15; 14(2):81-97. PubMed ID: 9063651
    [Abstract] [Full Text] [Related]

  • 18. Variability of cortisol and adrenocorticotropic hormone responses to metoclopramide during the menstrual cycle.
    Seki K.
    Gynecol Obstet Invest; 1989 Mar 15; 27(4):201-3. PubMed ID: 2545573
    [Abstract] [Full Text] [Related]

  • 19. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects.
    Watabe T, Tanaka K, Hasegawa M, Miyabe S, Shimizu N.
    Endocrinol Jpn; 1985 Oct 15; 32(5):771-9. PubMed ID: 3004929
    [Abstract] [Full Text] [Related]

  • 20. The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects.
    Inder WJ, Livesey JH, Ellis MJ, Evans MJ, Donald RA.
    Clin Endocrinol (Oxf); 1996 Jan 15; 44(1):7-13. PubMed ID: 8706296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.